Evidence map›Paper›PMID 29748836›Full record

ArticleJapanese journal of radiology2018

Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancers.

Nobuyoshi Fukumitsu, Toshiyuki Okumura, Yuichi Hiroshima, Toshiki Ishida, Haruko Numajiri, Keiko Nemoto Murofushi, Kayoko Ohnishi, Teruhito Aihara, Hitoshi Ishikawa, Koji Tsuboi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Japanese journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nobuyoshi FukumitsuDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan. fukumitsun@yahoo.co.jp.ORCID http://orcid.org/0000-0003-2417-8199
Toshiyuki OkumuraDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Yuichi HiroshimaDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Toshiki IshidaDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Haruko NumajiriDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Keiko Nemoto MurofushiDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Kayoko OhnishiDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Teruhito AiharaDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Hitoshi IshikawaDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Koji TsuboiDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.
Hideyuki SakuraiDepartment of Radiation Oncology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, 305-8575, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study is to investigate the dose distribution of proton beam therapy (PBT) using a concomitant boost technique for unresectable pancreatic cancers. MATERIALS AND

methodsThis simulation study involved 36 patients with unresectable pancreatic cancer. The irradiation dose was set as 67.5 gray equivalent (GyE) with 25 fractions using concomitant boost technique. The irradiation dose was set as 50 GyE to cover the whole target and another posterior beam of 17.5 GyE was added to ensure that 10% isodose line was not delivered to the gastrointestinal (GI) tract. Dose distribution of the gross tumor volume and GI tract was examined.

resultsV

conclusionsWe found that irradiated dose is closely related to the distance from the GI tract. Clinically, this protocol is expected to have outstanding effects on local control of tumors compared to conventional PBT.

Indexed as

AdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPancreatic NeoplasmsProton TherapyRadiometryRadiotherapy DosageConcomitant boost techniqueGross tumor volumePancreatic cancerProton beam therapy

Identifiers

PMID29748836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.